Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Story3
Saba Capital reports $23.1m stake in Invesco Senior Income Trust, flags possible board nominations and liquidation push
A Schedule 13D filed on 4 November 2026 shows Saba Capital Management, L.P. disclosed a stake in Invesco Senior Income Trust bought for approximately $23,061,256 and said it may seek board seats, propose buy-backs or push for the fund's liquidation.
Digital Brands Group receives default notice from Shakawe Capital on $3,529,412 convertible note
An 8-K filed on 2 November 2026 shows Digital Brands Group, Inc. received a written notice of default from Shakawe Capital LLC on 29 October 2026 over a $3,529,412 convertible promissory note, with the holder asserting the note is now due in full at 120% of outstanding amounts.
Main Street Capital files Schedule 13D on MSC Income Fund stake, says it has no plans to act under items (a) through (j)
The Schedule 13D filed on 4 November 2026 shows Main Street Capital Corp reporting a position in MSC Income Fund, Inc. and stating it has no present plans or proposals of the kind listed in Item 4 of the form.
Company or person1
Colon Flor
Company
Primary record20
Kirklees Council awarded £26,132 to Allerton Damp Proofing
Kirklees Council awarded a contract to Allerton Damp Proofing worth £26,132 on 2026-09-24. Contract: Specialist Works Framework - Laurel Drive. Lot 2 - Timber Infestation Treatment Category: Solid flooring.
London Borough of Waltham Forest awarded £2,509,494 to Borras Construction Ltd
London Borough of Waltham Forest awarded a contract to Borras Construction Ltd worth £2,509,494 on 2025-02-18. Contract: Vestry House Museum Refurbishment Works. The proposed project is the refurbishment and alteration o
BIOVIE INC. filed SCHEDULE 13G/A
0001595888-26-000133.txt : 20261106 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001595888-26-000114 0001595888 XXXXXXXX LIVE 1 Class A Common Stock, Par Value $0.0001 Per Share 09/30/2026 0001580149 BIOVIE INC
Saba Capital Management, L.P. filed SCHEDULE 13D/A
, the beneficial owner of the Common Shares reported herein. The address of the business office of each of the Reporting Persons is 405 Lexington Avenue, 58th Floor, New York, New York 10174. The principal business of: (
North Northamptonshire Council awarded £377,147 to Johnson Healthtech UK Limited
North Northamptonshire Council awarded a contract to Johnson Healthtech UK Limited worth £377,147 on 2026-11-03. Contract: North Northamptonshire Council - FOR REPLACEMENT GYM EQUIPMENT - CORBY EAST MIDLANDS INTERNATIONA
Bambusa Therapeutics, Inc. filed SCHEDULE 13D
, as amended, (the "Act") is filed as Exhibit 99.1. The Reporting Persons' ownership of the Issuer's securities includes (i) 5,933,787 shares of common stock held directly by the Fund; and (ii) 1,495,971 shares of common
HELU CARLOS SLIM filed SCHEDULE 13D
0000921895-26-002956.txt : 20261106 SCHEDULE 13D 1 primary_doc.xml X0202 SCHEDULE 13D 0001080910 XXXXXXXX LIVE Preferred Shares, Class A, without par value per share 10/30/2026 false 0001071438 105532105 BRASKEM SA RUA E
Blue Acquisition Corp/Cayman filed SCHEDULE 13G/A
0000905148-26-004669.txt : 20261106 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001856405 XXXXXXXX LIVE 2 Class A Ordinary Shares, par value $0.0001 per share 10/31/2026 0002059654 Blue Acquisition Corp. G1331
HARROW, INC. filed SCHEDULE 13G/A
, as amended, or otherwise. One Boston Place, 26th Floor, Boston, MA 02108 Opaleye Management Inc. - Massachusetts Opaleye, L.P. - Delaware James Silverman - United States Y 2,105,000.00 5.62 % 0 2,105,000.00 0 2,105,000
Pono Capital Four, Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. As previously disclosed, on August 5, 2026, Pono Capital Four, Inc. (“Pono” or “Parent”), a Cayman Islands exempted company (which shall de-register from the Registe
Latigo Biotherapeutics, Inc. filed SCHEDULE 13G/A
(the "SEC") on November 5, 2026. Access Industries Holdings LLC DE 0 3193565 0 3193565 3193565 N 4.8 OO (1) The percentage reported herein is calculated based upon 66,299,347 shares of Common Stock outstanding as of Nove
RenX Enterprises Corp. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement On November 2, 2026, RenX Enterprises Corp. (the “Company”) entered into an exchange agreement (the “Exchange Agreement”) with an accredited investor (the “Investor”),
Brilliant Earth Group, Inc. filed SCHEDULE 13G/A
0001193125-26-452170.txt : 20261106 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001883367 XXXXXXXX LIVE 3 Class A common stock, $0.0001 par value per share 09/30/2026 0001866757 Brilliant Earth Group, Inc. 109
Boston Partners filed SCHEDULE 13G/A
0001386060-26-000052.txt : 20261106 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001386060-26-000027 0001386060 XXXXXXXX LIVE 3 American Depositary Shares, each twenty (20) ADSs representing one (1) Common Shar
JANE STREET GROUP, LLC filed SCHEDULE 13G/A
0001595888-26-000151.txt : 20261106 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001595888-26-000117 0001595888 XXXXXXXX LIVE 1 Class A Common Stock, par value $0.0001 per share 09/30/2026 0001892292 Maison Sol
Airsculpt Technologies, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Financing Agreement On November 5, 2026 (the “Closing Date”), AirSculpt Technologies, Inc. (the “Company”), EBS Intermediate Parent LLC, a wholly-owned subsidiary of
Jaguar Health, Inc. filed 8-K
Item 5.07 Submission of Matters to a Vote of Security Holders. On November 6, 2026, Jaguar Health, Inc. (the “Company”) held a special meeting of stockholders of the Company (the “Special Meeting”). Six proposals were su
NEXTNRG, INC. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Exchange Agreement On November 2, 2026, NextNRG, Inc. (the “Company”) and its wholly owned subsidiary, NextNRG Holding Corp. (“NXXT Sub”), entered into a Debt Exchang
Opaleye Management Inc. filed SCHEDULE 13G/A
0001493152-26-050454.txt : 20261106 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001493152-26-021483 0001595855 XXXXXXXX LIVE 5 Ordinary Shares, par value NIS 1.00 per share. 09/30/2026 0001684693 Sol-Gel Techn
RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13D/A
(the "SEC") on February 9, 2018, and amended on July 30, 2019, December 16, 2020, March 23, 2021, September 6, 2022, October 4, 2022, December 5, 2022, January 11, 2024, June 12, 2024, February 21, 2025, August 14, 2025,